BioCentury
ARTICLE | Company News

Iroko, EMS deal

August 11, 2014 7:00 AM UTC

Iroko granted EMS exclusive rights to commercialize pain drug Zorvolex submicron diclofenac in Brazil. EMS will be responsible for regulatory and pricing approval in Brazil. Iroko said EMS plans to s...